Basic information
- Name:
Losartan
- CAS No.:
114798-26-4
- Molecular Structure:

- Formula:
- C22H23ClN6O
- Molecular Weight:
- 422.92
- Synonyms:
- 2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole;DUP 89;1H-imidazole-5-methanol, 2-butyl-4-chloro-1-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-;[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol;2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol;2-Butyl-4-chloro-1-[[2-(1H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol;Losartan Base;
- Density:
- 1.35 g/cm3
- Melting Point:
- 183-184 °C
- Boiling Point:
- 682 °C at 760mmHg
- Flash Point:
- 366.3 °C
- Appearance:
- pale yellow solid
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety Description:
- 26-36 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Chemistry
Molecule structure of Losartan (CAS NO.114798-26-4):

IUPAC Name: [2-Butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
Molecular Weight: 422.91062 g/mol
Molecular Formula: C22H23ClN6O
Density: 1.35 g/cm3
Melting Point: 183-184 °C
Boiling Point: 682 °C at 760 mmHg
Flash Point: 366.3 °C
Index of Refraction: 1.68
Molar Refractivity: 118.23 cm3
Molar Volume: 312.5 cm3
Surface Tension: 53.3 dyne/cm
Enthalpy of Vaporization: 105.1 kJ/mol
Vapour Pressure: 1.55E-19 mmHg at 25 °C
H-Bond Donor: 2
H-Bond Acceptor: 5
Rotatable Bond Count: 8
Tautomer Count: 4
Exact Mass: 422.162187
MonoIsotopic Mass: 422.162187
Topological Polar Surface Area: 92.5
Heavy Atom Count: 30
Classification Code: Angiotensin II Type 1 Receptor Blockers; Anti-arrhythmia agents; Antihypertensive agents; Cardiovascular Agents; Drug / Therapeutic Agent; Human Data
Uses
Losartan (CAS NO.114798-26-4) is used mainly to treat high blood pressure (hypertension). Losartan is being researched as a possible drug for marked slowing of aortic enlargement in Marfan and related syndromes.
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| man | TDLo | oral | 7mg/kg/1W-I (7mg/kg) | SENSE ORGANS AND SPECIAL SENSES: CHANGE IN FUNCTION: TASTE LUNGS, THORAX, OR RESPIRATION: COUGH GASTROINTESTINAL: OTHER CHANGES | Annals of Internal Medicine. Vol. 129, Pg. 72, 1998. |
| man | TDLo | oral | 17500ug/kg/17 (17.5mg/kg) | SENSE ORGANS AND SPECIAL SENSES: CHANGE IN FUNCTION: TASTE | Lancet. Vol. 347, Pg. 471, 1996. |
| man | TDLo | oral | 18mg/kg/13W-I (18mg/kg) | SENSE ORGANS AND SPECIAL SENSES: CHANGE IN FUNCTION: TASTE | Annals of Internal Medicine. Vol. 129, Pg. 72, 1998. |
| man | TDLo | oral | 21429ug/kg/30 (21.429mg/kg) | JAMA, Journal of the American Medical Association. Vol. 278, Pg. 1572, 1997. | |
| man | TDLo | oral | 21429ug/kg/30 (21.429mg/kg) | LIVER: LIVER FUNCTION TESTS IMPAIRED LIVER: OTHER CHANGES | JAMA, Journal of the American Medical Association. Vol. 278, Pg. 1572, 1997. |
| women | TDLo | oral | 42mg/kg/6W-I (42mg/kg) | GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" KIDNEY, URETER, AND BLADDER: URINE VOLUME DECREASED | Annals of Internal Medicine. Vol. 124, Pg. 775, 1996. |
Safety Profile
Hazard Codes:
Xi
Risk Statements: 36/37/38
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing.
Specification
Losartan (CAS NO.114798-26-4) is also named as Hyzaar ; DUP 89 ; UNII-JMS50MPO89 ; 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'- biphenyl)-4-yl)methyl)- . Losartan (CAS NO.114798-26-4) is pale yellow solid.

